Knockdown of PIM-1 expression in pancreatic cancer cells suppressed proliferation, induced cell cycle arrest, enhanced apoptosis, resensitized cells to gemcitabine and erlotinib treatment, and inhibited ABCG2 and EZH2 mRNA expression. The gene discussed is ABCG2; the disease is pancreatic neoplasm.